IL1B and Alzheimer disease: For instance, chronic over-expression of IL-1β (Shaftel et al., 2007; Matousek et al., 2012), or a reduced amount of anti-inflammatory IL-10 can reduce Aβ plaques in animal models of AD (Guillot-Sestier et al., 2015a).